Company intelligence / Profile preview

Invenomic Capital Management

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Invenomic Capital Management is an investment management firm headquartered in Boston, Massachusetts. Founded in 2017 by Ali Motamed, the firm specializes in a fundamental, bottom-up investment approach, primarily managing the Invenomic Fund. While the firm is a generalist equity investor, it maintains significant institutional exposure to the healthcare and life sciences sectors as part of its diversified long/short equity strategy. The firm is known for its focus on undervalued companies with strong cash flows and its disciplined approach to risk management. Invenomic provides investment advisory services to pooled investment vehicles and institutional clients.

Industry: Investors

Beyond the preview

Go deeper on Invenomic Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Invenomic Capital Management.

Explore the full profile